SANTANDREA, GIACOMO
 Distribuzione geografica
Continente #
AS - Asia 1.218
NA - Nord America 1.126
EU - Europa 652
SA - Sud America 180
AF - Africa 63
OC - Oceania 11
Totale 3.250
Nazione #
US - Stati Uniti d'America 1.084
CN - Cina 435
SG - Singapore 296
IT - Italia 241
HK - Hong Kong 162
BR - Brasile 145
GB - Regno Unito 99
VN - Vietnam 75
RU - Federazione Russa 61
KR - Corea 57
DE - Germania 56
SE - Svezia 54
ID - Indonesia 36
EG - Egitto 32
FI - Finlandia 27
IN - India 27
IR - Iran 23
MX - Messico 21
PK - Pakistan 20
AR - Argentina 19
NL - Olanda 19
FR - Francia 18
IQ - Iraq 18
CA - Canada 17
PL - Polonia 16
ZA - Sudafrica 14
LT - Lituania 13
BD - Bangladesh 12
AU - Australia 11
TR - Turchia 11
PH - Filippine 9
EC - Ecuador 8
JP - Giappone 8
UA - Ucraina 7
AT - Austria 6
ES - Italia 6
IL - Israele 6
NG - Nigeria 6
CO - Colombia 5
BG - Bulgaria 4
CH - Svizzera 4
MA - Marocco 4
MY - Malesia 4
PT - Portogallo 4
RS - Serbia 4
SA - Arabia Saudita 4
AM - Armenia 3
IE - Irlanda 3
PA - Panama 3
AE - Emirati Arabi Uniti 2
BF - Burkina Faso 2
ET - Etiopia 2
RO - Romania 2
SN - Senegal 2
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
OM - Oman 1
PY - Paraguay 1
QA - Qatar 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.250
Città #
Santa Clara 269
Hefei 227
Ashburn 202
Singapore 183
Hong Kong 150
London 56
San Jose 51
Beijing 46
Seoul 44
Los Angeles 40
New York 38
Chandler 35
Ho Chi Minh City 31
Milan 26
Chicago 22
Jakarta 22
Cairo 21
Fairfield 21
Helsinki 20
Nyköping 20
Shanghai 20
Buffalo 19
São Paulo 19
The Dalles 18
Kent 16
Munich 16
Moscow 15
Warsaw 14
Bologna 13
Johannesburg 12
Rome 11
Florence 9
Islamabad 9
Naples 9
Nuremberg 9
Salt Lake City 9
Brembate di Sopra 8
Denver 8
Wuhan 8
Atlanta 7
Cambridge 7
Guayaquil 7
Orem 7
Rio de Janeiro 7
Tokyo 7
Bari 6
Giza 6
Hanoi 6
Houston 6
Mexico City 6
Portsmouth 6
Redondo Beach 6
Amsterdam 5
Ann Arbor 5
Baghdad 5
Bagno a Ripoli 5
Boston 5
Brooklyn 5
Campi Bisenzio 5
Catania 5
Council Bluffs 5
Dhaka 5
Manchester 5
Migliarino 5
Montreal 5
Parma 5
San Diego 5
Seattle 5
Turku 5
Austin 4
Belgrade 4
Belo Horizonte 4
Bremen 4
Dallas 4
Düsseldorf 4
Istanbul 4
Lagos 4
Lauterbourg 4
Modena 4
Perth 4
Poplar 4
Porto Alegre 4
Princeton 4
Round Rock 4
Rutigliano 4
Sha Tin Wai 4
Sofia 4
Songpa-gu 4
Stockholm 4
Sunderland 4
Ankara 3
Appignano 3
Belfast 3
Buenos Aires 3
Chennai 3
Da Nang 3
Dublin 3
Elk Grove Village 3
Erbil 3
Genoa 3
Totale 2.049
Nome #
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 489
Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center 195
How can we treat vulvar carcinoma in pregnancy? A systematic review of the literature 168
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 152
Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature 152
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variables 149
Biomarkers changes after neoadjuvant chemotherapy in breast cancer: A seven-year single institution experience 132
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 130
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 124
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. part 4: Experimental treatments in pre-clinical studies (cell lines and mouse models) 121
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 5: Epigenetic regulation of pd-l1 120
Clinically unquestionable but histologically deceptive melanomas in acral skin grafts: PRAME confirms its role 119
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer 117
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. Part 3: PD-L1, intracellular signaling pathways and tumor microenvironment 108
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 2: Clinic–pathologic correlations 108
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 104
PRAME expression in cellular neurothekeoma: A study of 11 cases 103
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 100
Digital spatial profiling for pathologists 96
Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion 96
LncRNA TAZ-AS202 promotes lung cancer progression through the regulation of the E2F1 transcription factor 95
null 83
A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures 66
Harnessing the hypoxia pathway to set a new therapeutic strategy for KRAS-mutated lung adenocarcinoma 63
Characterization of EGLN1 as a pro-oncogenic factor and pharmacological target in lung cancer 59
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer 35
Totale 3.284
Categoria #
all - tutte 14.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/202267 11 18 0 0 2 6 3 8 2 2 8 7
2022/2023129 9 12 6 5 10 14 2 15 12 13 14 17
2023/2024442 17 17 30 40 53 40 61 42 18 48 38 38
2024/20251.233 18 41 45 100 215 175 115 65 147 53 118 141
2025/20261.403 221 157 221 295 332 94 83 0 0 0 0 0
Totale 3.284